Altre lingue Diagonal Bio AB

Azioni

DIABIO

SE0015961826

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:23:34 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,0752 ^SEK	-5,41%		-13,96%	-78,70%

05/04	Diagonal Bio AB (Publ) annuncia l'estensione della sua partnership con la Clinica Veterinaria Horsholm	CI
05/04	Diagonal Bio AB (Publ) annuncia i risultati di uno studio pilota di successo	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Diagonal Bio AB announces outcome of rights issue	24/04
Diagonal Bio AB publish - White paper	16/04
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	10/04
The subscription period in Diagonal Bio AB rights issue commences today	08/04
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces Successful Pilot Study Results	05/04
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	03/04
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	02/04
Diagonal Bio Makes Interim CEO Permanent	29/02
Diagonal Bio appoints Karin Wehlin as new CEO	28/02
Diagonal Bio Appoints Karin Wehlin as New CEO	28/02
Notice to attend the extraordinary general meeting of Diagonal Bio AB	28/02
The Board of Directors decides on a preferential rights issue of units in order to finance future development	28/02
Diagonal Bio AB Year-end Report 2023	28/02
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Diagonal Bio Signs Product Distribution Deal With Techtum Lab	16/02
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding	22/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Diagonal Bio AB

Azioni

DIABIO

SE0015961826

Altre lingue

Filtri